Is CRISPR Therapeutics (CRSP) Attractive After Recent Share Price Pullback? [Yahoo! Finance]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: Yahoo! Finance
If you are wondering whether CRISPR Therapeutics at around US$45.75 is a bargain or a value trap, the answer depends on how you look at its valuation. The stock has returned 23.7% over the last year, but that sits alongside a 17.1% decline over the past 30 days and a 14.9% decline year to date, which can change how investors think about both opportunity and risk. Recent attention around CRISPR Therapeutics has focused on its position in gene editing and how market sentiment reacts to clinical and regulatory milestones in this space. These kinds of updates often influence how the share price behaves in the short term, even when the long term thesis is unchanged. Right now, CRISPR Therapeutics scores 3 out of 6 on Simply Wall St's valuation checks, as shown by its valuation score . It passes half of the tests for being undervalued. The next sections break this down across different valuation methods and also point to a richer way to think about value at the end of the article.
Show less
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- CRISPR Therapeutics AG (CRSP) Rises Higher Than Market: Key Facts [Yahoo! Finance]Yahoo! Finance
- I Expect Crispr Therapeutics To Break Out As 2026 Revenue Exceeds Expectations [Seeking Alpha]Seeking Alpha
- CRISPR (CRSP) Rated Overweight on Gene Editing Growth [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics (CRSP) was upgraded by Truist Financial Corporation to "strong-buy".MarketBeat
- Learn From The Leaders: Biotech Stock Research On Seeking Alpha | Ed Ingham's 6-Tab Method [Seeking Alpha]Seeking Alpha
CRSP
Earnings
- 2/12/26 - Miss
CRSP
Sec Filings
- 4/2/26 - Form PRE
- 3/24/26 - Form 4
- 3/24/26 - Form 4
- CRSP's page on the SEC website